Intelligence · Clinical Pipeline
Axsome Therapeutics Pipeline
All ClinicalTrials.gov programs at Axsome Therapeutics — phase, modality, and trial IDs.
- Programs
- 5
Quick answer
Axsome Therapeutics has 5 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
AXS-05
Axsome Therapeutics
Smoking Cessation
1 trial -
AXS-05
Axsome Therapeutics
Treatment Resistant Depression
1 trial -
AXS-05 (dextromethorphan-bupropion)
Axsome Therapeutics
Treatment Resistant Depression
1 trial -
Dextromethorphan-Bupropion
Axsome Therapeutics
Major Depressive Disorder (MDD)
1 trial -
Solriamfetol
Axsome Therapeutics
Multiple Sclerosis
1 trial
Frequently asked questions
How many pipeline programs does Axsome Therapeutics have?
5 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs